These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 9884382)
1. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Greinacher A; Völpel H; Janssens U; Hach-Wunderle V; Kemkes-Matthes B; Eichler P; Mueller-Velten HG; Pötzsch B Circulation; 1999 Jan 5-12; 99(1):73-80. PubMed ID: 9884382 [TBL] [Abstract][Full Text] [Related]
2. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators. Greinacher A; Janssens U; Berg G; Böck M; Kwasny H; Kemkes-Matthes B; Eichler P; Völpel H; Pötzsch B; Luz M Circulation; 1999 Aug; 100(6):587-93. PubMed ID: 10441094 [TBL] [Abstract][Full Text] [Related]
3. Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis. Fischer KG; van de Loo A; Böhler J Kidney Int Suppl; 1999 Nov; (72):S46-50. PubMed ID: 10560805 [TBL] [Abstract][Full Text] [Related]
4. Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: incidence, effects on aPTT, and clinical relevance. Eichler P; Friesen HJ; Lubenow N; Jaeger B; Greinacher A Blood; 2000 Oct; 96(7):2373-8. PubMed ID: 11001886 [TBL] [Abstract][Full Text] [Related]
5. Recombinant hirudin anticoagulation for aortic valve replacement in heparin-induced thrombocytopenia. Longrois D; de Maistre E; Bischoff N; Dopff C; Meistelman C; Angioï M; Lecompte T Can J Anaesth; 2000 Mar; 47(3):255-60. PubMed ID: 10730738 [TBL] [Abstract][Full Text] [Related]
6. Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies. Mudaliar JH; Liem TK; Nichols WK; Spadone DP; Silver D J Vasc Surg; 2001 Jul; 34(1):17-20. PubMed ID: 11436069 [TBL] [Abstract][Full Text] [Related]
7. Continuous haemofiltration with r-hirudin (lepirudin) as anticoagulant in a patient with heparin induced thrombocytopenia (HIT II). Schneider T; Heuer B; Deller A; Boesken WH Wien Klin Wochenschr; 2000 Jun; 112(12):552-5. PubMed ID: 10953874 [TBL] [Abstract][Full Text] [Related]
8. [Prevention of thrombosis with subcutaneous recombinant hirudin in heparin-induced thrombocytopenia type II. A pilot study]. Huhle G; Hoffmann U; Hoffmann I; Harenberg J; Heene DL Dtsch Med Wochenschr; 2000 Jun; 125(22):686-91. PubMed ID: 10874895 [TBL] [Abstract][Full Text] [Related]
9. Lepirudin for prophylaxis of thrombosis in patients with acute isolated heparin-induced thrombocytopenia: an analysis of 3 prospective studies. Lubenow N; Eichler P; Lietz T; Farner B; Greinacher A Blood; 2004 Nov; 104(10):3072-7. PubMed ID: 15280202 [TBL] [Abstract][Full Text] [Related]
10. Recombinant hirudin (lepirudin) for the improvement of thrombolysis with streptokinase in patients with acute myocardial infarction: results of the HIT-4 trial. Neuhaus KL; Molhoek GP; Zeymer U; Tebbe U; Wegscheider K; Schröder R; Camez A; Laarman GJ; Grollier GM; Lok DJ; Kuckuck H; Lazarus P J Am Coll Cardiol; 1999 Oct; 34(4):966-73. PubMed ID: 10520777 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulation for patients with heparin-induced thrombocytopenia using recombinant hirudin during cardiopulmonary bypass. Liu H; Fleming NW; Moore PG J Clin Anesth; 2002 Sep; 14(6):452-5. PubMed ID: 12393116 [TBL] [Abstract][Full Text] [Related]
12. Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia. Reilly MP; Weiss R; Askenase A; Tuite C; Soulen M; Mohler ER Vasc Med; 2000; 5(4):239-42. PubMed ID: 11213236 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia. Dang CH; Durkalski VL; Nappi JM Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503 [TBL] [Abstract][Full Text] [Related]
14. A new therapeutic option by subcutaneous recombinant hirudin in patients with heparin-induced thrombocytopenia type II: a pilot study. Huhle G; Hoffmann U; Hoffmann I; Liebe V; Harenberg JF; Heene DL Thromb Res; 2000 Aug; 99(4):325-34. PubMed ID: 10963783 [TBL] [Abstract][Full Text] [Related]
15. A comparison of danaparoid and lepirudin in heparin-induced thrombocytopenia. Farner B; Eichler P; Kroll H; Greinacher A Thromb Haemost; 2001 Jun; 85(6):950-7. PubMed ID: 11434701 [TBL] [Abstract][Full Text] [Related]
16. Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis. Dager WE; White RH Ann Pharmacother; 2001; 35(7-8):885-90. PubMed ID: 11485140 [TBL] [Abstract][Full Text] [Related]
17. Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. Lubenow N; Eichler P; Lietz T; Greinacher A; J Thromb Haemost; 2005 Nov; 3(11):2428-36. PubMed ID: 16241940 [TBL] [Abstract][Full Text] [Related]
18. A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience. Curzio KM; Cheng-Lai A; Kheyfets V; Sinnet M; Billett HH J Thromb Thrombolysis; 2009 Aug; 28(2):117-23. PubMed ID: 18827975 [TBL] [Abstract][Full Text] [Related]